Purpose
|
WP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL cells, shows activity to JAK2, STAT3, STAT5, and ERK1/2 not JAK1 and JAK3. Phase 1.
|
Characteristics
|
Target: JAK inhibitor, STAT inhibitor Receptor: JAK2,STAT3
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
97?% +
|
Formula
|
C17H14BrN3O
|
Solubility
|
200 mM in DMSO
|